<DOC>
	<DOCNO>NCT01843972</DOCNO>
	<brief_summary>To investigate safety , tolerability , pharmacokinetics ( PK ) , pharmacodynamics single rise dos BI 691751 healthy male subject ( part I ) . To investigate relative bioavailability BI 691751 give tablet versus oral solution ( part II )</brief_summary>
	<brief_title>Safety Single Rising Doses Relative Bioavailability BI 691751</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Inclusion criterion : 1 . Healthy male subject 2 . Subjects must able understand comply study requirement 3 . Age 18 55 year 4 . BMI range : 18.5 29.9 kg/m2 5 . Known genotype specify study protocol Exclusion criterion : 1 . Any relevant deviation healthy condition</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>